CAVA enters its June 22 earnings print having surged 14% on the week to $87.30, yet with a short base that has barely flinched — creating an unusually charged setup heading into one of the most-watched restaurant prints of the season.
The rally has compressed the gap between price and the Street's mean target of $92. Two weeks ago that implied roughly 20% upside from $76; today it's closer to 5%. The analyst picture has been broadly constructive. UBS upgraded to Buy on June 10, lifting its target to $90. RBC, Piper Sandler, and Telsey all raised targets following the May Q1 print, with RBC at $105 the most bullish on the Street. Barclays remains the outlier, holding Equal-Weight with a $74 target — still well below where the stock now trades. The consensus sits at Buy across 14 names, with 9 at Hold. The bull case centers on same-store sales momentum, digital engagement, and new unit productivity in expansion markets. Bears point to input cost pressure, skewed customer demographics, and a valuation that, at roughly 48x EV/EBITDA, leaves no room for execution missteps.
Positioning in the lending market is notably loose given the size of the short base. Short interest has climbed to 12% of the free float — up 11% over the past month, and tracking near multi-month highs — yet borrow availability remains wide at 318%, meaning there are more than three shares available to lend for every one currently borrowed. The cost to borrow has barely moved, sitting at just 0.46%. There is no evidence of squeeze pressure building in the borrow market; the short base is large but well-supplied. Options traders have edged more cautious as the stock ran higher. The put/call ratio now reads 0.79, modestly above its 20-day average of 0.74 and running near the upper half of its one-year range. The z-score of 0.86 flags mild defensiveness, not alarm — but the direction of travel over the past two weeks has been consistently toward more hedging as price climbed.
The most interesting insider signal in recent weeks came from the operational level. CAVA's COO Douglas Thompson bought 6,500 shares across two transactions in late May — paying $79.45 and $79.00 per share — committing roughly $512,000 of personal capital at prices well below where the stock closed this week. The Company Secretary added 2,000 shares across the same period. On the other side, routine sales from the Chief Accounting Officer and a small disposal from co-founder Ted Xenohristos are a less meaningful signal. The net 90-day insider position is modestly positive at roughly $3 million bought against a smaller sell tally, with the buying concentrated in operationally senior hands. AllianceBernstein was the most active institutional mover in recent filings, adding 1.7 million shares, a more than 20% increase in its position. BlackRock and T. Rowe Price also added, albeit in smaller size.
The prior two earnings prints showed contained reactions — a 4% gain on the most recent Q1 in May, and just under 1% on the print before that. Peers have broadly matched CAVA's run this week: BROS gained 14.3%, SG rose 14.4%, and SHAK added 12.3%, suggesting sector-wide strength rather than a CAVA-specific re-rating. The June 22 print now becomes primarily a test of whether current same-store sales trends justify a stock that has already priced in much of the analyst community's optimism — and whether 12% short interest at a loose borrow has the conviction to hold through the number.
See the live data behind this article on ORTEX.
Open CAVA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
